Joseph Jankovic Explained

Joseph Jankovic
Workplaces:Baylor College of Medicine
Alma Mater:University of Arizona College of Medicine

Joseph Jankovic is an American neurologist and professor at Baylor College of Medicine in Houston, Texas. He is the Distinguished Chair in Movement Disorders and founder and director of the Parkinson's Disease Center and Movement Disorders Clinic.[1]

Career

Jankovic received his M.D. from the University of Arizona College of Medicine in 1973. He completed his internship at Baylor College of Medicine and residency in neurology at Columbia University, where he was chief resident. He joined the faculty of Baylor College of Medicine in 1977 and was promoted to full professor in 1988. He currently holds the Distinguished Chair in Movement Disorders.

Jankovic has served as the principal investigator in numerous clinical trials. His research is in etiology, pathogenesis, and classification of various movement disorders and on experimental therapeutics. Jankovic has contributed to classifications, characterization, and therapeutic guidelines of various movement disorders. His research on drugs for parkinsonian disorders and hyperkinetic movement disorders, including botulinum toxin[2] and tetrabenazine,[3] has led to their approval by the United States Food and Drug Administration.

Jankovic is certified by the American Board of Psychiatry and Neurology. He has served on the editorial boards of several journals, including Neurology, Movement Disorders, Journal of Neurology Neurosurgery and Psychiatry, Parkinsonism and Related Disorders, Acta Neurologica Scandinavica, Journal of the Neurological Sciences, Medlink, Neurotherapeutics, Tremor and Other Hyperkinetic Movements, Journal of Parkinson’s Disease, Faculty of 1000, Toxins, Drugs, and Frontiers in Neurology. He is the editor-in-chief for Expert Review of Neurotherapeutics. He has served on the executive scientific advisory boards of the Michael J. Fox Foundation for Parkinson’s Research. He has published over 1,200 original articles and over 50 books, including several standard textbooks such as Neurology in Clinical Practice and Principles and Practice of Movement Disorders.

Under his leadership, the Parkinson's Disease Center and Movement Disorders Clinic has been recognized as a "Center of Excellence" by the Parkinson’s Foundation,[4] the Huntington's Disease Society of America, the Tourette Association of America,[5] and the Wilson Disease Association.

Honors

[6]

[8]

Notes and References

  1. Web site: Parkinson's Disease Center & Movement Disorders Clinic, Joseph Jankovic, M.D.. Jankovic.org. 30 January 2018.
  2. Botulinum toxin: State of the art. Joseph. Jankovic. 1 August 2017. Movement Disorders. 32. 8. 1131–1138. 10.1002/mds.27072. 28639368. 33005319.
  3. Dopamine depleters in the treatment of hyperkinetic movement disorders. Joseph. Jankovic. 1 December 2016. Expert Opinion on Pharmacotherapy. 17. 18. 2461–2470. 10.1080/14656566.2016.1258063. 27819145. 5669255.
  4. Web site: Expert PF Centers. Parkinson's Foundation. en. 2018-04-26.
  5. Web site: Centers of Excellence Locations. Tourette Association of America. 2018-04-26. en-US.
  6. https://www.bcm.edu/neurology-apps/cv.cfm?id=josephj
  7. Web site: Joseph Jankovic, MD. International Neurotoxin Association. en-US. 2018-04-26.
  8. Web site: Joseph Jankovic, M.D.. Baylor College of Medicine. 30 January 2018.